• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacologic control of thromboembolic complications of cardiac-valve replacement.

作者信息

Sullivan J M, Harken D E, Gorlin R

出版信息

N Engl J Med. 1971 Jun 24;284(25):1391-4. doi: 10.1056/NEJM197106242842501.

DOI:10.1056/NEJM197106242842501
PMID:4931099
Abstract
摘要

相似文献

1
Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
N Engl J Med. 1971 Jun 24;284(25):1391-4. doi: 10.1056/NEJM197106242842501.
2
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.心脏瓣膜置换术后血栓栓塞并发症的药物控制。初步报告。
N Engl J Med. 1968 Sep 12;279(11):576-80. doi: 10.1056/NEJM196809122791104.
3
Use of Persantine in preventing thromboembolism following valve replacement.
Am Surg. 1972 Aug;38(8):432-5.
4
Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.抗血小板药物与风湿性心脏病患者中圣犹达医疗主动脉瓣膜假体血栓栓塞并发症的发生率
J Thorac Cardiovasc Surg. 1986 Jan;91(1):92-8.
5
[Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].[人工瓣膜置换患者全身血栓栓塞意外的预防。抗维生素K-双嘧达莫联合用药的前瞻性研究]
Arch Mal Coeur Vaiss. 1982 Jan;75(1):85-8.
6
Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.双嘧达莫-阿司匹林用于人工主动脉瓣置换术后患者的血栓栓塞预防。对型号为2320的斯塔尔-爱德华兹人工瓣膜进行的前瞻性研究。
J Thorac Cardiovasc Surg. 1981 Apr;81(4):632-5.
7
Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.使用圣犹达医疗心脏瓣膜假体的低剂量口服抗凝和抗血小板治疗。
J Heart Valve Dis. 1999 Nov;8(6):665-73.
8
Late incidence and determinants of stroke after aortic and mitral valve replacement.主动脉瓣和二尖瓣置换术后卒中的晚期发生率及决定因素
Ann Thorac Surg. 2004 Jul;78(1):77-83; discussion 83-4. doi: 10.1016/j.athoracsur.2003.12.058.
9
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.对于接受生物瓣二尖瓣置换术且合并房颤的患者，无需进行口服抗凝治疗。
Z Kardiol. 1986;75 Suppl 2:321-5.
10
Can early thromboembolic complications after valve replacement be avoided?
Z Kardiol. 1986;75 Suppl 2:302-4.

引用本文的文献

1
Antiplatelet and anticoagulation for patients with prosthetic heart valves.人工心脏瓣膜患者的抗血小板和抗凝治疗
Cochrane Database Syst Rev. 2013 Jul 9;2013(7):CD003464. doi: 10.1002/14651858.CD003464.pub2.
2
Plasminogen activators and ischemic stroke: conditions for acute delivery.纤溶酶原激活物与缺血性脑卒中：急性给药的条件。
Semin Thromb Hemost. 2013 Jun;39(4):406-25. doi: 10.1055/s-0033-1338126. Epub 2013 Mar 28.
3
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
瓣膜疾病的抗栓和溶栓治疗：抗栓治疗与血栓预防，第 9 版：美国胸科医师学院循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e576S-e600S. doi: 10.1378/chest.11-2305.
4
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.双嘧达莫通过内分泌亚硝酸盐/一氧化氮依赖途径增强缺血诱导的动脉生成。
Cardiovasc Res. 2010 Mar 1;85(4):661-70. doi: 10.1093/cvr/cvq002. Epub 2010 Jan 8.
5
Biography of Barry S. Coller.巴里·S·科勒传记。
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13111-3. doi: 10.1073/pnas.0405839101. Epub 2004 Aug 30.
6
Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and Design.联合血液疗法与死亡率预防（CHAMP）研究原理与设计
J Thromb Thrombolysis. 1998 Sep;6(2):133-140. doi: 10.1023/A:1008853622289.
7
Do we still need dipyridamole?我们仍然需要双嘧达莫吗？
Br J Clin Pharmacol. 1998 Apr;45(4):323-8. doi: 10.1046/j.1365-2125.1998.t01-1-00677.x.
8
Antiplatelet therapy--Part II.抗血小板治疗——第二部分。
West J Med. 1993 May;158(5):506-14.
9
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
10
Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.磺吡酮治疗改善心脏溶血性贫血。
Can Med Assoc J. 1980 Mar 8;122(5):554-6.